Sheldon L. Holder, Ph.D.
Affiliations: | 2005 | Loma Linda University, Loma Linda, United States |
Area:
Molecular Biology, Microbiology BiologyGoogle:
"Sheldon Holder"Parents
Sign in to add mentor| Michael B. Lilly | grad student | 2005 | Loma Linda University | |
| (Identification and characterization of a selective inhibitor of the PIM -1 kinase.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Holder SL, Warrick J, Zhu J, et al. (2020) A phase Ib study targeting PIM1 and CDK4/6 kinases in metastatic renal cell carcinoma (PICKRCC). Journal of Clinical Oncology. 38 |
| Joshi M, Warrick JI, Yin M, et al. (2019) Need for a personalized approach for muscle invasive bladder cancer: role of tumor biology in response to neoadjuvant chemotherapy. Translational Andrology and Urology. 8: S99-S103 |
| Wheelden M, Kaag M, Zhu J, et al. (2019) Small cell bladder carcinoma: Single institution experience. Journal of Clinical Oncology. 37: 468-468 |
| Joshi M, Tuanquin L, Kaag M, et al. (2018) Phase Ib study of concurrent durvalumab and radiation therapy (DUART) followed by adjuvant durvalumab in patients with urothelial cancer of the bladder: BTCRC-GU15-023 study. Journal of Clinical Oncology. 36: 455-455 |
| Small J, Washburn E, Millington K, et al. (2017) The addition of abemaciclib to sunitinib induces regression of renal cell carcinoma xenograft tumors. Oncotarget. 8: 95116-95134 |
| Holder SL, Small J. (2017) An evaluation of abemaciclib activity in combination with sunitinib in renal cell carcinoma. Journal of Clinical Oncology. 35: 452-452 |
| Joshi M, Millis SZ, Arguello D, et al. (2016) Molecular Characterization of Bladder Cancer in Smokers versus Nonsmokers. European Urology Focus |
| Yin M, Joshi M, Meijer RP, et al. (2016) Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer: A Systemic Review and Two-Step Meta-Analysis. The Oncologist |
| Matthew EM, Zhou L, Yang Z, et al. (2015) A multiplexed marker-based algorithm for diagnosis of carcinoma of unknown primary using circulating tumor cells. Oncotarget |
| Wang W, Cheng J, Mallon C, et al. (2015) Symptomatic Secondary Polycythemia Induced by Anti-VEGF Therapy for the Treatment of Metastatic Renal Cell Carcinoma: A Case Series and Review. Clinical Genitourinary Cancer |